(Q39041602)

English

Establishment, characterization and comparison of seven authentic anaplastic thyroid cancer cell lines retaining clinical features of the original tumors

scientific article published on March 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Establishment, characterization and comparison of seven authentic anaplastic thyroid cancer cell lines retaining clinical features of the original tumors (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

anaplastic thyroid cancer

1 reference

based on heuristic

inferred from title

author name string

Naoyoshi Onoda

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Masanori Nakamura

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Naoki Aomatsu

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Satoru Noda

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Shinichiro Kashiwagi

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Kosei Hirakawa

6

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

publication date

1 March 2014

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

World Journal of Surgery

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

38

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

688-695

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Approach to the patient with anaplastic thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2409-7

21 January 2018

Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2409-7

21 January 2018

Treatment with tyrosine kinase inhibitors for patients with differentiated thyroid cancer: the M. D. Anderson experience

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2409-7

21 January 2018

Emerging therapies in sight for the fight against dedifferentiated thyroid cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2409-7

21 January 2018

BRAF V600E inhibition in anaplastic thyroid cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2409-7

21 January 2018

A phase II trial of rosiglitazone in patients with thyroglobulin-positive and radioiodine-negative differentiated thyroid cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2409-7

21 January 2018

Redifferentiation and induction of tumor suppressors miR-122 and miR-375 by the PAX8/PPARγ fusion protein inhibits anaplastic thyroid cancer: a novel therapeutic strategy

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2409-7

21 January 2018

Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2409-7

21 January 2018

Establishment and characterization of OCUT-1, an undifferentiated thyroid cancer cell line expressing high level of telomerase

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2409-7

21 January 2018

Efficacy of epidermal growth factor receptor-targeted molecular therapy in anaplastic thyroid cancer cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2409-7

21 January 2018

Peroxisome proliferator-activated receptor gamma activation induces cell cycle arrest via the p53-independent pathway in human anaplastic thyroid cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2409-7

21 January 2018

Genetic alterations in the phosphoinositide 3-kinase/Akt signaling pathway confer sensitivity of thyroid cancer cells to therapeutic targeting of Akt and mammalian target of rapamycin

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2409-7

21 January 2018

Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2409-7

21 January 2018

p53 gene mutations associated with anaplastic transformation of human thyroid carcinomas

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2409-7

21 January 2018

A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2409-7

21 January 2018

Identification of Polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2409-7

21 January 2018

Copy number alteration and uniparental disomy analysis categorizes Japanese papillary thyroid carcinomas into distinct groups

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2409-7

21 January 2018

Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2409-7

21 January 2018

Induction chemotherapy with weekly paclitaxel administration for anaplastic thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2409-7

21 January 2018

The feasibility study of docetaxel in patients with anaplastic thyroid cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2409-7

21 January 2018

Sunitinib exerts only limited effects on the proliferation and differentiation of anaplastic thyroid cancer cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2409-7

21 January 2018

Paneling human thyroid cancer cell lines for candidate proteins for targeted anti-angiogenic therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2409-7

21 January 2018

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2409-7

21 January 2018

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2409-7

21 January 2018

American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2409-7

21 January 2018

Immunohistochemical detection of epithelialmesenchymal transition associated with stemness phenotype in anaplastic thyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24357248

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific subtelomere loss on chromosome der(11)t(3;11)(q23;q23)x2 in anaplastic thyroid cancer cell line OCUT-1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24357248

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24357248

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-level genomic instability is a feature of papillary thyroid carcinoma: an array comparative genomic hybridization study of laser capture microdissected papillary thyroid carcinoma tumors and clonal cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/24357248

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A rapid banding technique for human chromosomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/24357248

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00268-013-2409-7

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39041602&oldid=2202496151"